Septerna, Inc. (SEPN)
41.86
-6.70
(-13.80%)
USD |
NASDAQ |
Nov 12, 16:00
41.27
-0.59
(-1.41%)
After-Hours: 20:00
Septerna Total Liabilities (Quarterly) : 191.48M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 191.48M |
| June 30, 2026 | 180.02M |
| March 31, 2026 | 191.23M |
| December 31, 2025 | 220.06M |
| September 30, 2025 | 217.92M |
| June 30, 2025 | 37.67M |
| Date | Value |
|---|---|
| March 31, 2025 | 33.75M |
| December 31, 2024 | 36.51M |
| September 30, 2024 | 37.53M |
| June 30, 2024 | 20.24M |
| March 31, 2024 | |
| December 31, 2023 | 20.03M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| Arvinas, Inc. | 93.70M |
| Fulcrum Therapeutics, Inc. | 13.26M |
| Definium Therapeutics, Inc. | 106.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 619.40M |
| Shareholders Equity (Quarterly) | 427.93M |
| Debt to Equity Ratio | 0.0514 |
| Current Ratio | 4.838 |
| Net Debt Paydown Yield | 0.03% |